CytomX Therapeutics
CTMX
CTMX
74 hedge funds and large institutions have $61.9M invested in CytomX Therapeutics in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
36% less capital invested
Capital invested by funds: $97.1M → $61.9M (-$35.3M)
52% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 27
Holders
74
Holding in Top 10
–
Calls
$30K
Puts
$43K
Top Buyers
| 1 | +$7.72M | |
| 2 | +$1.64M | |
| 3 | +$1.46M | |
| 4 |
Millennium Management
New York
|
+$1.43M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.22M |
Top Sellers
| 1 | -$7.73M | |
| 2 | -$3.48M | |
| 3 | -$1.98M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$1.67M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.11M |